Trypanosome Lytic Factor, an Antimicrobial High-Density Lipoprotein, Ameliorates Leishmania Infection
Open Access
- 23 January 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 5 (1), e1000276
- https://doi.org/10.1371/journal.ppat.1000276
Abstract
Innate immunity is the first line of defense against invading microorganisms. Trypanosome Lytic Factor (TLF) is a minor sub-fraction of human high-density lipoprotein that provides innate immunity by completely protecting humans from infection by most species of African trypanosomes, which belong to the Kinetoplastida order. Herein, we demonstrate the broader protective effects of human TLF, which inhibits intracellular infection by Leishmania, a kinetoplastid that replicates in phagolysosomes of macrophages. We show that TLF accumulates within the parasitophorous vacuole of macrophages in vitro and reduces the number of Leishmania metacyclic promastigotes, but not amastigotes. We do not detect any activation of the macrophages by TLF in the presence or absence of Leishmania, and therefore propose that TLF directly damages the parasite in the acidic parasitophorous vacuole. To investigate the physiological relevance of this observation, we have reconstituted lytic activity in vivo by generating mice that express the two main protein components of TLFs: human apolipoprotein L-I and haptoglobin-related protein. Both proteins are expressed in mice at levels equivalent to those found in humans and circulate within high-density lipoproteins. We find that TLF mice can ameliorate an infection with Leishmania by significantly reducing the pathogen burden. In contrast, TLF mice were not protected against infection by the kinetoplastid Trypanosoma cruzi, which infects many cell types and transiently passes through a phagolysosome. We conclude that TLF not only determines species specificity for African trypanosomes, but can also ameliorate an infection with Leishmania, while having no effect on T. cruzi. We propose that TLFs are a component of the innate immune system that can limit infections by their ability to selectively damage pathogens in phagolysosomes within the reticuloendothelial system.Keywords
This publication has 48 references indexed in Scilit:
- In Vivo Imaging Reveals an Essential Role for Neutrophils in Leishmaniasis Transmitted by Sand FliesScience, 2008
- Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse modelThe Journal of Experimental Medicine, 2008
- Hemoglobin Is a Co-Factor of Human Trypanosome Lytic FactorPLoS Pathogens, 2007
- Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serumProceedings of the National Academy of Sciences, 2007
- A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomesThe Journal of Experimental Medicine, 2006
- Leishmania–Host-cell Interaction: Complexities and Alternative ViewsParasitology Today, 2000
- Identification of Proteins Associated with Apolipoprotein A-I-Containing Lipoproteins Purified by Selected-Affinity ImmunosorptionBiochemistry, 1994
- Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vesicular Proton-ATPaseScience, 1994
- The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments.The Journal of Experimental Medicine, 1990
- Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroyCell, 1982